今日晚间重要公告抢先看——8连板胜通能源称公司不涉及机器人相关业务，收购方不存在未来十二个 月内的资产重组计划；2连板利柏特称公司不涉及可控核聚变业务；珠免集团已完成格力房产100%股权 交割，交易价格为55.18亿元。 【重大事项】 8连板胜通能源：公司不涉及机器人相关业务收购方不存在未来十二个月内的资产重组计划 胜通能源（001331）公告，公司股票自12月12日以来连续8个交易日涨停，累计涨幅达到114.44%，属 于股票交易严重异常波动的情形。公司控股股东、实际控制人签署了《关于胜通能源股份有限公司之股 份转让协议》。公司不涉及机器人相关业务，公司主营业务仍为液化天然气采购、运输及销售，未发生 重大变化，收购方不存在未来十二个月内的资产重组计划，收购方不存在未来12个月内对上市公司及其 子公司的资产和业务进行出售、合并、与他人合资或合作的计划，或上市公司拟购买或置换资产的重组 计划，收购方不存在未来36个月内通过上市公司借壳上市的计划或安排。收购方七腾机器人参与本次收 购的资金来源为自有资金及自筹资金，截至目前，自筹资金的申请仍在审批阶段，是否可以申请成功尚 存在不确定性，敬请广大投资者注意投资风险， ...

Group 1 - Shareholder of Okoyi plans to reduce holdings by up to 1.89% of the company's shares, amounting to a maximum of 3 million shares due to personal funding needs [1] - Tianchuang Fashion is planning a change in control, leading to continued suspension of its stock trading, expected to last no more than 3 trading days [2] - China Electric Power Construction Company reported a new contract amount of 10,317.55 billion yuan for the first 11 months of 2025, a year-on-year decrease of 1.65% [3] Group 2 - Pilin Bio's wholly-owned subsidiary received approval for a clinical trial of a drug, indicating progress in its product development [4] - Yihong Medical obtained two medical device registration certificates for diagnostic kits, enhancing its product portfolio [5] - Aohong Electronics plans to use up to 450 million yuan of idle fundraising for cash management, targeting safe and liquid financial products [6] Group 3 - China Electric Power Construction signed a contract worth approximately 6.626 billion yuan for a natural gas booster station project in Turkey, with a construction period of about 55 months [7] - Baosheng Co. won a bid for a power cable project in Singapore, valued at around 1.2 billion yuan, marking the largest overseas order in its history [8] - *ST Xinyan's stock will resume trading on December 24, 2025, following a capital increase plan that will raise its total share capital to 3.29 billion shares [9] Group 4 - Ningbo Construction's subsidiary signed a construction contract worth 428 million yuan for an engineering project with a duration of 990 days [11] - Lianhuan Pharmaceutical's subsidiary received approval for a drug that passed the consistency evaluation for generic drugs, enhancing its market competitiveness [12] - Zhongjie Automotive received a project designation for a new electric air conditioning compressor, with expected sales of approximately 29.86 million USD over its lifecycle [13] Group 5 - Biopharmaceuticals' major shareholder plans to increase holdings by 50 million to 100 million yuan, indicating confidence in the company's future [14] - Haizheng Pharmaceutical's subsidiary received approval for a veterinary drug product, expanding its product offerings in the animal health sector [15] - *ST Songfa's subsidiary signed contracts for the construction of 8 vessels, with a total contract value between 200 million to 400 million USD [16] Group 6 - Shandong Pharmaceutical Glass announced the resignation of its chairman due to age reasons, indicating a potential leadership transition [17] - Xinno Wei's subsidiary received approval for a clinical trial of a monoclonal antibody drug, indicating advancements in its drug development pipeline [18] - Ningbo Huaxiang's subsidiary secured an order for robot joints, expected to positively impact future business performance [19][20] Group 7 - China Resources Double Crane's subsidiary received approval for a clinical trial of a drug aimed at treating a genetic eye disease, reflecting ongoing R&D efforts [21] - Huaxin Technology's shareholders set a transfer price of 56.69 yuan per share for a block of shares, indicating active shareholder engagement [22] - Xinhua Net announced the resignation of its president due to job relocation, suggesting potential changes in management [23] Group 8 - Taiji Group plans to transfer a 40% stake in a subsidiary to focus on its core pharmaceutical business, enhancing operational efficiency [24] - Huaxin Construction's shareholder plans to increase holdings by 200 million to 400 million yuan, reflecting confidence in the company's prospects [25] - Dongjie Intelligent is planning to issue shares and cash for asset acquisition, with stock trading suspended until further notice [26] Group 9 - Wanrun New Energy was designated as a delivery warehouse for lithium carbonate futures, indicating its strategic position in the market [27] - Prolo Pharmaceutical's subsidiary received a drug registration certificate for an influenza treatment, expanding its product range [28] - Saiwu Technology invested 5 million yuan in a private equity fund focused on smart vehicles and energy innovation, indicating strategic investment in growth sectors [29] Group 10 - Bohui Innovation's subsidiary received approval for a clinical trial of an immunoglobulin drug, indicating progress in its product development [30] - Bohui Innovation's subsidiary also received a drug registration certificate for a coagulation factor product, enhancing its therapeutic offerings [31] - Hanghua Co. plans to allocate 146 million yuan of surplus fundraising for a new green printing materials project, reflecting a commitment to sustainability [32] Group 11 - Nova Star Cloud obtained a loan commitment letter from a bank for a share repurchase plan, indicating financial support for its capital management strategy [33] - Jimin Health established a joint venture for technology innovation, indicating a strategic move to enhance its technological capabilities [34] - Huili Pharmaceutical received a drug registration certificate for a medication used in treating digestive ulcers, expanding its product portfolio [35]

人民财讯12月23日电，诺瓦星云（301589）12月23日公告，近日，公司取得招商银行西安分行出具的 《贷款承诺函》，同意为公司提供不超过1.35亿元专项贷款融资支持，用于回购公司股份。此次回购资 金总额不低于7500万元且不超过1.5亿元，回购价格不超过240元/股。 ...

格隆汇12月23日丨诺瓦星云(301589.SZ)公布，近日，公司取得招商银行股份有限公司西安分行出具的 《贷款承诺函》，同意为公司提供本次回购公司股份专项贷款融资支持。主要内容如下：1.贷款银行： 招商银行股份有限公司西安分行；2.贷款额度：不超过人民币13,500万元；3.贷款期限：36个月；4.贷款 用途：专项用于回购本公司股票。 ...

格隆汇12月23日丨诺瓦星云(301589.SZ)公布，近日，公司取得招商银行股份有限公司西安分行出具的 《贷款承诺函》，同意为公司提供本次回购公司股份专项贷款融资支持。主要内容如下：1.贷款银行： 招商银行股份有限公司西安分行；2.贷款额度：不超过人民币13,500万元；3.贷款期限：36个月；4.贷款 用途：专项用于回购本公司股票。 ...

近日，公司取得招商银行股份有限公司西安分行出具的《贷款承诺函》，同 意为公司提供本次回购公司股份专项贷款融资支持。主要内容如下： 证券代码：301589 证券简称：诺瓦星云 公告编号：2025-093 西安诺瓦星云科技股份有限公司 关于取得金融机构回购专项贷款承诺函的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、回购股份的基本情况 西安诺瓦星云科技股份有限公司（以下简称"公司"）于 2025 年 12 月 16 日 召开第三届董事会第十次会议，审议通过了《关于第四期回购公司股份方案的议 案》，同意公司使用自有资金或自筹资金以集中竞价交易方式回购公司部分已发 行的人民币普通股（A 股）股票，回购的股份将用于股权激励、员工持股计划或 可转换公司债券转股。本次回购资金总额不低于人民币 7,500 万元，不超过人民 币 15,000 万元（均包含本数），回购价格不超过人民币 240.00 元/股（含本数）。 按照回购价格上限和回购金额下限测算，预计回购股份数量为 312,500 股，约占 公司目前已发行总股本的 0.34%；按照回购价格上限和回购金额上限测 ...

证券代码：301589 证券简称：诺瓦星云 公告编号：2025-092 西安诺瓦星云科技股份有限公司 注：以上股东的持股数量为合并普通账户和融资融券信用账户后总的持股数量。 | | | | 占无限售条件 | | --- | --- | --- | --- | | 序号 | 股东名称 | 持股数量（股） | 股份总数比例 | | | | | （%） | | 1 | 西安高新技术产业风险投资有限责任公司 | 4,212,000 | 12.22 | | 2 | 赵小明 | 3,659,300 | 10.62 | | 3 | 西安诺瓦星云科技股份有限公司 | 2,720,327 | 7.89 | | | 回购专用证券账户 | | | | | 民生证券－兴业银行－民生证券诺瓦星云 | | | | 4 | 战略配售 号集合资产管理计划 1 | 2,308,691 | 6.70 | | 5 | 向健华 | 1,774,200 | 5.15 | | 6 | 全国社保基金一一零组合 | 560,969 | 1.63 | | 7 | 深圳市艾比森光电股份有限公司 | 523,901 | 1.52 | | 8 | 兴业期货－兴业银 ...

证券日报网讯12月19日，诺瓦星云（301589）在互动平台回答投资者提问时表示，公司目前产能利用率 较高，未来公司将持续关注市场动态，审慎评估客户需求与行业趋势，对产能进行合理规划与布局。 ...

（编辑 王雪儿） 证券日报网讯 12月19日，诺瓦星云在互动平台回答投资者提问时表示，公司XR虚拟拍摄解决方案在电 视剧、短剧、短视频及电影等领域均有应用。关于公司参与项目的具体情况可关注公司官网与诺瓦星云 订阅号、服务号、视频号等。 ...

Core Insights - The article presents a ranking of the most profitable new stocks since the implementation of the comprehensive irrigation system on February 17, 2023, highlighting their first-day performance [2][3]. Summary by Sections Stock Performance - The top-performing new stock is C沐曦-U, which had an issuance price of 104.66 and closed at 829.90, achieving a closing increase of 692.95% and a peak increase of 755.15% [3]. - The second-ranked stock, 暨尔线程-U, was issued at 114.28 and closed at 600.50, with a closing increase of 425.46% and a peak increase of 502.03% [3]. - 长联科技, ranked third, had an issuance price of 21.12 and closed at 381.00, resulting in a closing increase of 1,703.98% and a peak increase of 1,831.82% [3][4]. - Other notable mentions include 红四方, 诺瓦星云, and 中国瑞林, which also demonstrated significant first-day performance with closing increases ranging from 202.62% to 1,917.42% [4]. Market Trends - The article indicates a trend of substantial returns for new stocks, particularly in the 科创板 and 创业板 segments, suggesting a robust market environment for new listings [2][3][4].